Estadístiques de Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.
Visites totals
| views | |
|---|---|
| Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial. | 257 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| verstovsek-hoe-ruxo.pdf(legacy) | 495 |
| verstovsek-hoe-ruxo.pdf | 51 |
Vistes principals per país
| views | |
|---|---|
| United States | 169 |
| France | 22 |
| Germany | 14 |
| Sweden | 9 |
| United Kingdom | 8 |
| Spain | 6 |
| China | 5 |
| Belgium | 4 |
| Canada | 3 |
| Ireland | 3 |
| India | 2 |
| Italy | 2 |
| Poland | 2 |
| Russia | 2 |
| Ukraine | 2 |
| Australia | 1 |
| Czechia | 1 |
| Malaysia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ashburn | 36 |
| Fairfield | 29 |
| Ann Arbor | 8 |
| Mountain View | 7 |
| Cambridge | 6 |
| Menlo Park | 6 |
| Barcelona | 5 |
| Beijing | 5 |
| Redwood City | 5 |
| Sunnyvale | 4 |
| Tustin | 4 |
| Aberdeen | 3 |
| Boardman | 3 |
| Dublin | 3 |
| Falls Church | 3 |
| San Diego | 3 |
| San Ramon | 3 |
| Fremont | 2 |
| Rezé | 2 |
| Seattle | 2 |
| Warsaw | 2 |
| Bracknell | 1 |
| Des Moines | 1 |
| Hyderabad | 1 |
| Jacksonville | 1 |
| Kolkata | 1 |
| Magdeburg | 1 |
| Mississauga | 1 |
| Montréal | 1 |
| Pauls Valley | 1 |
| Phoenix | 1 |
| Portland | 1 |
| Premiá De Mar | 1 |
| Shah Alam | 1 |
| Stockholm | 1 |
| Toronto | 1 |
| Wilmington | 1 |
| Woodbridge | 1 |